These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 37151527)
1. Clickable Shiga Toxin B Subunit for Drug Delivery in Cancer Therapy. Danielewicz N; Rosato F; Tomisch J; Gräber J; Wiltschi B; Striedner G; Römer W; Mairhofer J ACS Omega; 2023 May; 8(17):15406-15421. PubMed ID: 37151527 [TBL] [Abstract][Full Text] [Related]
2. Gastric Adenocarcinomas Express the Glycosphingolipid Gb3/CD77: Targeting of Gastric Cancer Cells with Shiga Toxin B-Subunit. Geyer PE; Maak M; Nitsche U; Perl M; Novotny A; Slotta-Huspenina J; Dransart E; Holtorf A; Johannes L; Janssen KP Mol Cancer Ther; 2016 May; 15(5):1008-17. PubMed ID: 26826119 [TBL] [Abstract][Full Text] [Related]
3. A Shiga Toxin B-Subunit-Based Lectibody Boosts T Cell Cytotoxicity towards Gb3-Positive Cancer Cells. Tomisch J; Busse V; Rosato F; Makshakova ON; Salavei P; Kittel AS; Gillon E; Lataster L; Imberty A; Meléndez AV; Römer W Cells; 2023 Jul; 12(14):. PubMed ID: 37508560 [TBL] [Abstract][Full Text] [Related]
4. Lectin-anticancer peptide fusion demonstrates a significant cancer-cell-selective cytotoxic effect and inspires the production of "clickable" anticancer peptide in Escherichia coli. Pasupuleti R; Riedl S; Saltor Núñez L; Karava M; Kumar V; Kourist R; Turnbull WB; Zweytick D; Wiltschi B Protein Sci; 2023 Dec; 32(12):e4830. PubMed ID: 37916438 [TBL] [Abstract][Full Text] [Related]
5. Repurposing the Pentameric B-Subunit of Shiga Toxin for Gb3-Targeted Immunotherapy of Colorectal Cancer by Rhamnose Conjugation. Liu Z; Li X; Lu Z; Qin X; Hong H; Zhou Z; Pieters RJ; Shi J; Wu Z J Pharm Sci; 2022 Oct; 111(10):2719-2729. PubMed ID: 35905973 [TBL] [Abstract][Full Text] [Related]
6. Targeted Shiga toxin-drug conjugates prepared via Cu-free click chemistry. Kostova V; Dransart E; Azoulay M; Brulle L; Bai SK; Florent JC; Johannes L; Schmidt F Bioorg Med Chem; 2015 Nov; 23(22):7150-7. PubMed ID: 26507432 [TBL] [Abstract][Full Text] [Related]
7. Potent in vitro antitumor activity of B-subunit of Shiga toxin conjugated to the diphtheria toxin against breast cancer. Mohseni Z; Sedighian H; Halabian R; Amani J; Behzadi E; Imani Fooladi AA Eur J Pharmacol; 2021 May; 899():174057. PubMed ID: 33753109 [TBL] [Abstract][Full Text] [Related]
8. Preparation of Fluorescent Recombinant Shiga Toxin B Subunit and Its Application to Flow Cytometry. Yamaji T Methods Mol Biol; 2020; 2132():463-474. PubMed ID: 32306353 [TBL] [Abstract][Full Text] [Related]
9. Human breast cancer and lymph node metastases express Gb3 and can be targeted by STxB-vectorized chemotherapeutic compounds. Stimmer L; Dehay S; Nemati F; Massonnet G; Richon S; Decaudin D; Klijanienko J; Johannes L BMC Cancer; 2014 Dec; 14():916. PubMed ID: 25476116 [TBL] [Abstract][Full Text] [Related]
10. A new delivery system for auristatin in STxB-drug conjugate therapy. Batisse C; Dransart E; Ait Sarkouh R; Brulle L; Bai SK; Godefroy S; Johannes L; Schmidt F Eur J Med Chem; 2015 May; 95():483-91. PubMed ID: 25847766 [TBL] [Abstract][Full Text] [Related]
11. Tumor delivery of ultrasound contrast agents using Shiga toxin B subunit. Couture O; Dransart E; Dehay S; Nemati F; Decaudin D; Johannes L; Tanter M Mol Imaging; 2011 Apr; 10(2):135-43. PubMed ID: 21439258 [TBL] [Abstract][Full Text] [Related]
12. A real-time cell-binding assay reveals dynamic features of STxB-Gb3 cointernalization and STxB-mediated cargo delivery into cancer cells. Encarnação JC; Napolitano V; Opassi G; Danielson UH; Dubin G; Popowicz GM; Munier-Lehmann H; Buijs J; Andersson K; Björkelund H FEBS Lett; 2020 Aug; 594(15):2406-2420. PubMed ID: 32473599 [TBL] [Abstract][Full Text] [Related]
13. Tumor Targeting with Bacterial Shiga Toxin B Subunit in Genetic Porcine Models for Colorectal Cancer and Osteosarcoma. Ehrenfeld M; Schrade A; Flisikowska T; Perl M; Hirsch ND; Sichler A; Geyer L; Flisikowski K; Wilhelm D; Schober SJ; Johannes L; Schnieke A; Janssen KP Mol Cancer Ther; 2022 Apr; 21(4):686-699. PubMed ID: 35086950 [TBL] [Abstract][Full Text] [Related]
14. Differential recognition of lipid domains by two Gb3-binding lectins. Schubert T; Sych T; Madl J; Xu M; Omidvar R; Patalag LJ; Ries A; Kettelhoit K; Brandel A; Mely Y; Steinem C; Werz DB; Thuenauer R; Römer W Sci Rep; 2020 Jun; 10(1):9752. PubMed ID: 32546842 [TBL] [Abstract][Full Text] [Related]
15. Gb3-binding lectins as potential carriers for transcellular drug delivery. Müller SK; Wilhelm I; Schubert T; Zittlau K; Imberty A; Madl J; Eierhoff T; Thuenauer R; Römer W Expert Opin Drug Deliv; 2017 Feb; 14(2):141-153. PubMed ID: 27935765 [TBL] [Abstract][Full Text] [Related]
16. Designing and Analyzing the Structure of DT-STXB Fusion Protein as an Anti-tumor Agent: An Mohseni Moghadam Z; Halabian R; Sedighian H; Behzadi E; Amani J; Imani Fooladi AA Iran J Pathol; 2019; 14(4):305-312. PubMed ID: 31754360 [TBL] [Abstract][Full Text] [Related]
17. In vivo tumor targeting by the B-subunit of shiga toxin. Viel T; Dransart E; Nemati F; Henry E; Thézé B; Decaudin D; Lewandowski D; Boisgard R; Johannes L; Tavitian B Mol Imaging; 2008; 7(6):239-47. PubMed ID: 19123994 [TBL] [Abstract][Full Text] [Related]
18. Intracellular drug delivery: Potential usefulness of engineered Shiga toxin subunit B for targeted cancer therapy. Luginbuehl V; Meier N; Kovar K; Rohrer J Biotechnol Adv; 2018; 36(3):613-623. PubMed ID: 29432805 [TBL] [Abstract][Full Text] [Related]
19. Membrane invagination induced by Shiga toxin B-subunit: from molecular structure to tube formation. Pezeshkian W; Hansen AG; Johannes L; Khandelia H; Shillcock JC; Kumar PB; Ipsen JH Soft Matter; 2016 Jun; 12(23):5164-71. PubMed ID: 27070906 [TBL] [Abstract][Full Text] [Related]